Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France

Objective: The study assessed cost-effectiveness of follitropin alfa biosimilar versus the originator in terms of cost per cumulative live-birth (CLB) for the French healthcare system based on real-world evidence. Follitropin alfa biosimilars have been shown to have comparable clinical outcomes to t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Matthieu Lehmann (Autor), Elisangela Arbo (Autor), Jean-Luc Pouly (Autor), Paul Barrière (Autor), Lauren Amy Boland (Autor), Samuel George Bean (Autor), Julian Jenkins (Autor)
Formato: Livro
Publicado em: Elsevier, 2024-06-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Número de Chamada: A1234.567
Cópia 1 Disponível